AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
about
Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in LeukemiaThe Role of Histone Acetyltransferases in Normal and Malignant HematopoiesisThe RUNX genes: gain or loss of function in cancerGlobularity and language-readiness: generating new predictions by expanding the set of genes of interestMethylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.Phosphorylation-independent regulation of Atf1-promoted meiotic recombination by stress-activated, p38 kinase Spc1 of fission yeast.ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.Oncogenic potential of the RUNX gene family: 'overview'.Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast CancerLoss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasisPost-translational modifications of Runx1 regulate its activity in the cellNew insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.RUNX1 translocations and fusion genes in malignant hemopathies.AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.B-lineage transcription factors and cooperating gene lesions required for leukemia development.RUNX family: Regulation and diversification of roles through interacting proteins.Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cells.Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery.Posttranslational modifications of RUNX1 as potential anticancer targets.Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia.Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.Runx1 Structure and Function in Blood Cell Development.Covalent Modifications of RUNX Proteins: Structure Affects Function.RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.Systematic analysis of human lysine acetylation proteins and accurate prediction of human lysine acetylation through bi-relative adapted binomial score Bayes feature representation.Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.
P2860
Q26781526-D653486A-9B11-41B1-B998-50C950B0696BQ28088295-1AA8671F-F4CF-4041-B0C1-67CF74357D72Q28247901-509150A5-5919-45DF-BA3B-8A6A4D22E1D9Q28651479-F36C3FC3-014C-4EED-8A39-2FB5E4B7130EQ32884501-7FD6BE41-A7D3-4896-80C6-A242F0D2101AQ33444770-1F194540-B228-43E4-98C4-6EE054B47EA8Q33911196-E816DC5F-0CB9-49A1-A13B-4DA2D9AB29A3Q34150889-E2F8A62D-B2F9-4211-8A3D-3F29F7123852Q35650662-278C34EB-AC6A-4D5F-A40D-7C834125A2CCQ35779678-F4FC91E2-9A76-4CC4-9626-137EC4057B86Q35969130-338B5526-9F3F-4EF5-B5EA-36A96CC8BA26Q37201706-D0456947-477D-4ADD-AF06-04807F4430B3Q37455493-A0811F47-034C-4D54-B16E-AAEDAD2F1D17Q37679748-C839F0F9-E3D1-4A50-A198-537902298220Q37822736-6725A6FE-B11B-41E2-BC04-7F21708178A7Q38033116-BB7DFD2A-89AB-41C7-BADC-CE58443F4E31Q38050656-27606215-D83C-4E21-9DED-31565147DE94Q38062515-D0A55762-FFDE-4A36-A95A-CFB5DC475F08Q38172135-5ED783E8-3A16-401B-86F5-CC049B88E905Q38200653-F554F171-5E33-4FC5-86CE-A5014FE15E87Q38255068-7629A06C-8727-44FE-887E-40EBE89C5DACQ38275870-C07A5C75-9F4B-4977-AB2C-3BB50E8BDD07Q38320046-D46D20AF-C300-48ED-91AA-4BC19E1C849DQ38904253-AC878337-6A0C-49CE-ACEA-2B2E2C942235Q39181397-219B62D1-0386-4497-94D2-4BBD0A1B839DQ39914225-A66FC096-971A-4541-9D09-81A9C56AEBFFQ43810829-2256DB9C-FD7E-4582-B449-AD72275B96CCQ54515107-07C93E42-2B5F-4E7F-B909-2F4070AE0367Q55714869-EC8DAA44-3D84-4357-A289-31E584B16F2F
P2860
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
AML1 is functionally regulated ...... n on specific lysine residues.
@en
type
label
AML1 is functionally regulated ...... n on specific lysine residues.
@en
prefLabel
AML1 is functionally regulated ...... n on specific lysine residues.
@en
P2093
P2860
P356
P1476
AML1 is functionally regulated ...... on on specific lysine residues
@en
P2093
Eriko Nitta
Go Yamamoto
Hisamaru Hirai
Kazuki Sasaki
Kinuko Mitani
Mineo Kurokawa
Seishi Ogawa
Shigeru Chiba
Takashi Asai
Tetsuya Yamagata
P2860
P304
15630-15638
P356
10.1074/JBC.M400355200
P407
P577
2004-01-29T00:00:00Z